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EXECUTIVE SUMMARY
Abstract: Coagulopathy in trauma patients occurs due to tissue injury, hemodilution (dilution of
hematocrit and clotting factors), infusion of hypo-coagulable blood products (e.g., packed red
blood cells), acidosis, hypothermia, continued blood loss, and depletion of clotting factors. The
onset of coagulopathy begins with the initial tissue injury and evolves rapidly. Many factors need
consideration when determining resuscitative treatment for the trauma victim. These factors
include the amount of time for extraction from the field, transport time to a trauma center,
associated weather, and treatment provided in route. This study compared two clinical laboratory
pathways (Conventional Coagulation test and Rotational Thromboelastometry [ROTEM] whole
blood assay) to determine the influence on morbidity and mortality when trauma patients
received blood products perioperatively.
Introduction: Coagulopathy can begin at the point of injury and is called acute coagulopathy of
trauma or can be triggered in the presence of low body temperature, dilution, acidosis, and
expenditure of clotting factors and is called trauma-induced coagulopathy. Coagulopathy is a
critical condition and needs to be diagnosed early. Research on TEG/ROTEM whole blood
assays indicates a promising future in the use of these tests and the diagnosis and therapeutic
process for trauma patients.
Methodology: A retrospective, case-control investigation was carried out at The Charleston
Area Medical Center (CAMC) General Hospital Level 1 Trauma Center in West VA. The
hypotheses tested was when ROTEM whole blood assays are used to diagnose and predict the
number of blood products needed for patients receiving blunt force trauma or penetration to the
abdomen, the morbidity and mortality rate will decrease.
Results: The sample for the Conventional Coagulation Test consisted of 93 patients 18 years or
older with an average age of 42. The sample for the TEG/ROTEM whole blood assay consisted
of 43 patients 18 years or older with an average age of 44. There was no statistical significance
between ROTEM and Conventional tests and ISS, age, BMI, LOS, or the number of blood
products given a (p>0.05). No statistical significance was found between ROTEM and
Conventional tests and gender, AIS, and priority level 1 or 2 with a (p>0.05). No statistical
significance was found using the Fisher’s Exact test comparing ROTEM and Conventional tests
and the development of CHF or Pulmonary Edema with a (p>0.05). The results indicated that the
mortality rate was higher among the ROTEM group and was found to be statistically significant
with (p<0.05) compared to the Conventional group.
Discussion: CAMC General Hospital began using the ROTEM whole blood assay test on trauma
patients in 2014. For this study, there were only 43 ROTEM cases that could be used compared
to 100 Conventional Coagulation test cases. Future research should be conducted at CAMC
General Hospital on trauma patients receiving blood transfusions and the use of ROTEM whole
blood assay tests when more cases are available for comparison.
Conclusion: The working hypothesis for this study was trauma patients who received blood
transfusions guided by TEG/ROTEM whole blood assays received fewer blood products and had
a decreased morbidity and mortality rate than those who received blood transfusions guided by
Conventional Coagulation tests. Although, statistical significance was found between the
mortality rate and the case group no significance was found supporting the hypothesis due to the
lack of sufficient ROTEM cases.
Key Words: aPTT, Blood Transfusion, Platelets, PT, ROTEM, TEG, Trauma
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INTRODUCTION
Background
Coagulopathy is a condition of decreased clotting factors. In 2016, Chang, Cardenas,
Wade, and Holcomb reported that once a traumatic injury has occurred, the endothelium exhibits
anticoagulant properties. These features include thrombomodulin, endothelial protein C
receptors, and a glycocalyx element. According to Hinsbergh (2011), different factors activate
the cells within the endothelium to release these properties such as catecholamines, inflammatory
mediators, thrombin, and hypoxia. Cohen et al. (2012) reported that patients with a high Injury
Severity Score (ISS) and shock become coagulopathic from the moment of damage. Brohi,
Singh, Heron, and Coats (2003) stated an ISS greater than 45 upon admission indicates
coagulopathy.
According to Brohi et al. (2008), acute traumatic coagulopathy happens in the early phase
of the injury and is due to shock. These authors go on to state shock activates the anticoagulant
and fibrinolytic processes causing thrombomodulin to convert thrombin from a coagulant to an
anticoagulant and activating protein C in the presence of hypoperfusion. Another study by Brohi,
Cohen, and Davenport (2007), trauma-induced coagulopathy is characterized by dysfunction
through hemodilution with fluid administration or massive blood transfusion, hypothermia,
acidosis, or the consumption of clotting factors. Also, trauma patients commonly have a source
of uncontrolled hemorrhaging, and an immediate diagnosis of coagulopathy is necessary to
provide appropriate interventions (Schochl, Maegele, Solomon, Gorlinger, and Wolfgang, 2012).
Furthermore, once contributing factors have been considered such as extraction from the field,
transport time to a trauma center, associated weather, and treatment provided in route, a baseline
coagulation analysis must be obtained. Additionally, the conventional coagulation tests give an
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analysis of the Prothrombin Time (PT), International Normalized Ratio (INR), and activated
Partial Thromboplastin Time (aPTT) and are performed using only plasma (Schochl et al., 2012).
TEG and ROTEM are whole blood viscoelastic tests providing analysis at the initiation
of coagulation, the dynamics of clot formation, strength, and breakdown which provides a clear
internal view of the patient’s medical condition (Schochl et al., 2012).
Literature Review
Conventional Coagulation test:
According to Chowdhury, Saayman, Findlay, and Collins (2004), conventional
coagulation laboratory tests have been insufficient to determine the probability of bleeding or
predicting low levels of clotting factors. Simmons, Pittet, and Pierce (2014) stated that
conventional coagulation tests do not sufficiently evaluate the intricate processes that occur in a
patient with Trauma-Induced Coagulopathy (TIC). Furthermore, Conventional Coagulopathy
tests are performed on platelet reduced plasma and cannot evaluate the clot strength which can
produce negative results. Driessen et al., (2015), reported results from a web-based survey
among those attending the 15th European Congress of Trauma and Emergency Surgery in
Frankfurt, Germany in May of 2014. According to these authors, the results stated that out of
29% who responded, more than 74% admitted to using the conventional coagulation tests for
initial evaluation and continued monitoring of hemorrhaging trauma patients. Chitlur et al.
(2011), reported that routine laboratory tests including PT/INR, aPTT, and platelet function were
used for analyzing bleeding disorders. Additionally, enhanced knowledge of the clotting cascade
provided a better understanding of the function, at the cellular level, of white blood cells, red
blood cells, and platelets. Da Luz, Nascimento, and Rizoli (2013) stated that standard

2

coagulation assays used plasma which did not include platelets or the cellular element and
viscoelastic assays such as TEG or ROTEM uses whole blood samples.
Thromboelastography (TEG) and Rotational Thromboelastometry (ROTEM):
According to Ostrowski, Sorensen, Larsen, and Johansson (2011), data indicated that
TEG and ROTEM viscoelastic whole blood assays identified and distinguished which type of
coagulopathy was present. Furthermore, immediate recognition of coagulopathy is crucial to
plan the appropriate transfusion regimen. These authors also reported viscoelastic whole blood
assays had been used to direct and monitor transfusion interventions in hemorrhaging trauma
patients. Ostrowski et al. (2011), again stated TEG was specifically responsive to shifts in fibrin
and platelet function, and it was beneficial to discover changes and defects in the body’s blood
clotting ability perioperatively. Another study reported Thromboelastography provided
immediate results of clot strength and reliable data on coagulation activity and executed targetdirected transfusion treatment for trauma patients (Bollinger, Seeberger, and Kenichi, 2012).
According to Chitlur et al. (2011), TEG and ROTEM provide a total evaluation of the cellular
components starting with the initial clot production and ending with clot lysis. Hoffman and
Monroe (2001) stated that hemostasis has three different levels of coagulation. These authors
stated the first level is called initiation and takes place on the surface of the cells with tissue
factor, the second level is amplification and occurs on the platelet surface causing platelet
adhesion, and the final level is propagation where proteases and cofactors combine to generate
thrombin. According to Whiting and DiNardo, (2014), the primary clinical purpose for TEG or
ROTEM whole blood assays is the prompt return of results which lead to giving fast proper
attention to hemostatic deficiencies. Furthermore, TEG parameters include Clotting Index which
assesses the initial formation of a clot, Clot Strength, Elasticity, Thrombo-dynamic Potential
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Index obtained at maximum amplitude, Clot lysis at 30 and 60 minutes, and Estimated Percent
Lysis. Additionally, ROTEM parameters have included INTEM (contact activation), EXTEM
(tissue factor activation), APTEM (contains aprotinin for inhibiting fibrinolysis), and FIBTEM
(analysis of the fibrinogen contribution to clot strength) (Whiting and DiNardo, 2014).
Significance
Coagulopathy is a serious condition and is diagnosed immediately. Identification of the
type of coagulopathy and what interventions are necessary to sustain life are the first steps to
recovery. Conventional Coagulation tests utilize a small portion of the coagulation pathway
whereas TEG and ROTEM whole blood assays use the initial clot formation and follow through
to the breakdown of the clot.
Coagulopathy is evident upon admittance in 25% of patients involved in a traumatic
event and contributes to an increase in mortality rate (Brohi et al., 2007). Therefore, comparing
the outcomes of conventional coagulation tests to viscoelastic whole blood assays can provide a
better understanding of which pathway to utilize in diagnosing coagulopathy and appropriate
interventions for trauma patients.
Extensive research has been done on acute and trauma-induced coagulopathy. Research
has indicated that the timing of laboratory evaluation is imperative. Coagulopathy presents in the
acute phase immediately following a traumatic event due to the activation of protein C and
fibrinolysis, or as trauma-induced coagulopathy due to hemodilution, consumption of clotting
factors, acidosis, or hypothermia. The present study could enhance medical practice and improve
trauma patient outcomes at Charleston Area Medical Center, in West Virginia and other
hospitals.
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METHODOLOGY
Research Hypothesis
The working hypothesis for this study was trauma patients who received blood
transfusions guided by TEG/ROTEM whole blood assays received fewer blood products
presented a decreased morbidity and mortality rate than those who received blood transfusions
guided by Conventional Coagulation tests.
Research Design and Setting
This study was a retrospective, case-control investigation carried out at The Charleston
Area Medical Center (CAMC) General Hospital Level 1 Trauma Center in West Virginia. A
chart review of adult trauma patients who received blood products in response to Conventional
laboratory assay results or lab results from TEG/ROTEM whole blood assays were compared.
The case group consisted of trauma patients that had a TEG/ROTEM whole blood assay test, and
the morbidity or mortality that resulted from the interventions provided. The control group
consisted of trauma patients that had a Conventional Coagulation test, and the morbidity or
mortality rate that resulted from the interventions provided. This study design allowed for the
comparison of two laboratory pathways, statistical analysis, and the interventions provided.
Sample Population with Description
The CAMC General Hospital is a level 1 Trauma Center qualified to provide total care
for every form of injury (CAMC, 2017). An examination of medical records was performed on
136 priority one and two trauma patients who experienced blunt force trauma or penetration to
the abdominal cavity between the dates of January 1, 2006, through August 1, 2016. The medical
records were provided through CAMC EMR Sorian (Cerner, 2016).
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The patient’s sample for this study were identified using the International Classification
of Diseases, 9th and 10th revision, Clinical Modification (ICD-9-CM) or (ICD-10-CM) code for
blunt force trauma or penetration of the abdominal cavity (Centers for Disease Control and
Prevention, 2017).
Inclusion Criteria:
1) Adult male or female patients were18 years of age or older.
2) Patients who were involved in blunt force trauma or penetration to the abdominal cavity
and admitted to the CAMC General Hospital Trauma Center Emergency Department.
3) Priority 1 or 2 designated patients. Priority 1 (P1) or Priority 2 (P2) trauma patients were
transferred to the highest-level trauma center within 30-minutes or if greater than 30minutes the patient should be transferred to a nearby facility that was able to resuscitate
and stabilize the patient (West Virginia Department of Human Resources, 2017).
Exclusion Criteria:
1) Patients were younger than 18 years of age.
2) Any patient undergoing elective surgery.
3) Any patient considered non-trauma.
Procedures and Protocol
A retrospective, case-control study was performed utilizing patient electronic medical
records that experienced a traumatic event producing blunt force trauma or penetration to the
abdominal cavity between January 1, 2006 and August 1, 2016. Dependent variables included
morbidities (CHF or Pulmonary edema) that developed resulting from the transfusions and the
mortality rate. Patient demographic and clinical information was obtained and included: patients
who experienced a traumatic event produced by blunt force trauma or penetration to the
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abdominal cavity, age, ISS, body mass index (BMI), TEG or ROTEM whole blood assay test
results, Conventional Coagulation test results (PT/INR, aPTT, and Platelets), LOS in the
hospital, morbidities (CHF or Pulmonary Edema) developed resulting from intervention, and the
mortality rate.
The ISS is a structural grading arrangement that supplies a comprehensive score for
trauma patients with a combination of injuries (Osler, Nelson, and Bedrick, 1999). Additionally,
each injury is given an Abbreviated Injury Scale (AIS) score which includes six body zones
(Head, Face, Chest, Abdomen, Extremities). These authors also reported the greatest AIS
number for the individual body zones are used and the three most predominantly injured regions
scores are squared and totaled to provide an ISS score. Finally, the ISS ranges from 0-75, and if
the AIS score is 6 (an un-survivable injury), the ISS score will inevitably be 75 (Osler et al.,
1999).
Data Collection
The information gathered for this retrospective case-control investigation came from
existing data utilizing the patient’s electronic medical records (EMR) (Cerner, 2016). Microsoft
Excel was used to organize all data collection. Each patient was given a number, letter, or both
categorizing the data as it was collected and safeguarded the patient’s identification. This data
came from emergency department records, anesthesia records, and from other units at CAMC
where patients received care during the hospital stay. The demographic and clinical information
obtained was included: patients who received blunt force trauma or penetration to the abdominal
cavity, age, ISS, body mass index (BMI), TEG or ROTEM whole blood assay test results,
Conventional Coagulation test results (PT/INR, aPTT, and Platelets), length of stay in the
hospital, morbidities (CHF or Pulmonary Edema) developed resulting from intervention, and
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mortality rate. The BMI was calculated by a person’s weight and height and was used as a
predictor of body fat composition (CDC, 2011).
Statistical Analysis
The purpose of this study was to compare the outcomes using two laboratory pathways
(TEG/ROTEM or Conventional Coagulation) in patients who were involved in a traumatic event
that produced blunt force trauma or penetration to the abdominal cavity. Chi-square analysis was
done comparing the mortality rate against ROTEM and Conventional Coagulation tests. A t-test
was performed and compared means difference between two dependent variables (morbidity and
mortality) with ISS, age, BMI, LOS, and the number of blood products given. Three logistic
regression tests were performed to determine if there was an association between independent
variables ROTEM, age, BMI, gender, ISS with the dependent variables morbidity (CHF and
Pulmonary Edema) and mortality. A p-value <0.05 was considered statistically significant. The
data was analyzed using SPSS Version 24 (SPSS IBM Company, 2017).
RESULTS
Presentation, Analysis, and Interpretation of the Data
The study sample consisted of 136 patients over the age of 18, presenting to CAMC
General Hospital with a trauma injury of blunt force or penetration to the abdomen. The
following mean for ISS is 26.29  12.1, BMI 28.68  11, the age of the group was 43.15  17.9,
Number of Blood Products Used 20.36  35, and length of stay in the hospital 19.8  24.6 (Table
1). Of the 136 patients, 101 (74.1%) were male, 35 (25.9%) were female, 4 (2.9%) developed
CHF, 12 (8.8%) developed pulmonary edema and the mortality rate was 17 (12.5%), (Table 1).
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Table 1: Demographic and Clinical Characteristics of Adult Trauma Patients who received Blunt
Force Trauma or Penetration to the Abdomen
Total Sample

Study Groups
TEG/ROTEM Whole
Conventional
Blood Assay
Coagulation Test
N= 43 (31.6%)
N=93 (68.4%)
Mean (SD)
Mean (SD)

Statistical Value

Variables

Total
N=136
Mean (SD)

ISS

26.29 (12.1)

22.95 (11.5)

27.83 (12.1)

NS

Age (years)

43.15 (18)

44.56 (20)

42.49 (16.9)

NS

BMI (kg/m2)

28.68 (11)

30.12 (17.5)

28.01 (5.9)

NS

Hospital LOS (days)

19.81 (24.64)

18.51 (26.4)

20.41 (23.9)

NS

Number of Blood
Products

20.36 (34.94)

28.28 (51.4)

16.70 (23.3)

NS

Mortality (%)
1 - Alive
2 - Dead

1 – 118 (86.8%)
2 – 17 (12.5%)

1 – 34 (79.1%)
2 – 9 (20.9%)

1 – 85 (91.4%)
2 – 8 (8.6%)

*0.043

CHF (%)

4 (2.9%)

1 (2.3%)

3 (3.2%)

NS

Pulmonary Edema
(%)

12 (8.8%)

4 (9.3%)

8 (8.6%)

NS

Gender
1 – Male
2 - Female

1 – 100 (74.1%)
2 – 35 (25.9%)

1 – 30 (69.8%)
2 – 13 (30.2%)

1 – 71 (76.3%)
2 – 22 (23.7%)

NS

AIS ABD
2 – Moderate
3 – Serious
4 – Severe
5 – Critical

2 – 46 (33.8%)
3 – 44 (32.4%)
4 – 36 (26.5%)
5 – 10 (7.4%)

2 – 20 (46.5%)
3 – 11 (25.6%)
4 – 8 (18.6%)
5 – 4 (9.3%)

2 – 26 (28%)
3 – 33 (35.5%)
4 – 28 (30.1%)
5 – 6 (6.5%)

NS

1 – 105 (77.2%)
2 – 31 (22.8%)

1 – 34 (79.1%)
2 – 9 (20.9%)

1 – 71 (76.3%)
2 – 22 (23.7%)

Priority
1 and 2

p-Value

NS

*Indicates Statistical Significance at p<0.05, NS = Not Significant (p> .05), SD = Standard Deviation, ISS = Injury Severity
Score, BMI = Body Mass Index, LOS = Length of Stay, CHF = Congestive Heart Failure, TEG = Thromboelastography,
ROTEM = Rotational Thromboelastometry, AIS= Abbreviated Injury Scale

Comparison of the ROTEM whole blood assay (case group) and Conventional
Coagulation test (control group) did not show a mean difference between ISS, age, BMI, LOS, or
the number of blood products which were not statistically significant (p>0.05). Also,
comparison of the case group (ROTEM whole blood assay) and control group (Conventional
Coagulation test) did not show a statistical significance between gender, AIS, and Priority level
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with a (p>0.05). Mortality was associated with a higher percentage in case group (TEG/ROTEM
whole blood assay) which was statistically significant (p<0.05), (Table 1).
A Fisher’s Exact Test was performed comparing the use of ROTEM and Conventional
Coagulation tests with the development of pulmonary edema. The results indicated that 3.8 out
of 12 (33%) patients in the case group developed pulmonary edema with no statistical
significance (p >0.05), and 8.2 out of 12 (66.7%) developed pulmonary edema in the control
group with no statistical significance (p>0.05), (Table 2).
Table 2: Fisher’s Exact Test Comparing ROTEM and Conventional Coagulation tests with
Pulmonary Edema
TEG/ROTEM Whole Blood Assa1
(1/0)
0
Pulmonary Edema

0

Count
Expected Count
% within Pulmonary Edema
% within TEG/ROTEM
Whole Blood Assay (1/0)

1

Count
Expected Count
% within Pulmonary Edema
% within TEG/ROTEM
Whole Blood Assay (1/0)

Total

Count
Expected Count
% within Pulmonary Edema
% within TEG/ROTEM
Whole Blood Assay (1/0)

1

Total

85

39

124

84.8

39.2

124.0

68.5%

31.5%

100.0%

91.4%

90.7%

91.2%

8

4

12

8.2

3.8

12.0

66.7%

33.3%

100.0%

8.6%

9.3%

8.8%

93

43

136

93.0

43.0

136.0

68.4%

31.6%

100.0%

100.0%

100.0%

100.0%
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Value
Pearson Chi-Square
Continuity Correctionb
Likelihood Ratio

df

Asymp. Sig. (2-

Exact Sig. (2-

Exact Sig. (1-

sided)

sided)

sided)

.018*a

1

.894

.000

1

1.000

.018*

1

.894

Fisher's Exact Test

1.000

Linear-by-Linear Association

.018

N of Valid Cases

136

1

.562

.894

A Fisher’s Exact Test was performed comparing the use of ROTEM and Conventional
Coagulation tests and the development of CHF. The results indicated that of the patients in the
case group, only 1 (25%) out of 4 patients developed CHF. The results indicated that 3 out of 4
(75%) patients in the control group developed CHF with no statistical significance (p>0.05),
(Table 3).
Table 3: Fisher’s Exact Test Comparing ROTEM and Conventional Coagulation tests with CHF
TEG/ROTEM Whole Blood Assay
(1/0)
0
CHF (1/0)

0

Count
Expected Count
% within CHF (1/0)
% within TEG/ROTEM
Whole Blood Assay (1/0)

1

Count
Expected Count
% within CHF (1/0)
% within TEG/ROTEM
Whole Blood Assay (1/0)

Total

Count
Expected Count
% within CHF (1/0)
% within TEG/ROTEM
Whole Blood Assay (1/0)

1

Total

90

42

132

90.3

41.7

132.0

68.2%

31.8%

100.0%

96.8%

97.7%

97.1%

3

1

4

2.7

1.3

4.0

75.0%

25.0%

100.0%

3.2%

2.3%

2.9%

93

43

136

93.0

43.0

136.0

68.4%

31.6%

100.0%

100.0%

100.0%

100.0%
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Value
Pearson Chi-Square
Continuity

df

Likelihood Ratio

Exact Sig. (2-

Exact Sig. (1-

sided)

sided)

sided)

a

1

.773

.000

1

1.000

.087

1

.768

.083

Correctionb

Asymp. Sig. (2-

Fisher's Exact Test

1.000

Linear-by-Linear Association

.083

N of Valid Cases

136

1

.623

.773

A Pearson Chi-Square test was performed comparing the ROTEM group and the
mortality rate. The results indicated that the mortality rate was higher among the ROTEM group
9 (20.9%) compared to 8 (8.6%) in the Conventional group and was found to be statistically
significant with (p<0.05), (Table 4).
Table 4: Pearson Chi-Square Analysis of the ROTEM (case group) and the Mortality Rate
TEG/ROTEM Whole Blood Assa1 (1/0)
0
Mortality

1

(Alive-1 or Dead-2)

Count

85

34

81.4

37.6

71.4%

28.6%

91.4%

79.1%

Std. Residual

.4

-.6

Count

8

9

11.6

5.4

47.1%

52.9%

8.6%

20.9%

-1.1

1.6

93

43

93.0

43.0

68.4%

31.6%

100.0%

100.0%

Expected Count
% within Mortality (Alive-1 or Dead-2)
% within TEG/ROTEM Whole Blood
Assa1 (1/0)

2

Expected Count
% within Mortality (Alive-1 or Dead-2)
% within TEG/ROTEM Whole Blood
Assa1 (1/0)
Std. Residual
Total

1

Count
Expected Count
% within Mortality (Alive-1 or Dead-2)
% within TEG/ROTEM Whole Blood
Assa1 (1/0)
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Value
Pearson Chi-Square
Continuity

Correctionb

Likelihood Ratio

Asymp. Sig. (2-

Exact Sig. (2-

sided)

sided)

df
a

1

.043

3.036

1

.081

3.819

1

.051

4.086

Fisher's Exact Test
N of Valid Cases

Exact Sig. (1-sided)

.054

.044
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A t-test analysis was performed comparing the LOS between the ROTEM and
Conventional groups with no statistical significance found (p>0.05), (Table 5).
Table 5: T-test Analysis comparing LOS between ROTEM and Conventional Coagulation Tests
TEG/ROTEM Whole Blood
Assay (1/0)
Length of Stay

N

Mean

Std. Deviation

Std. Error Mean

0

93

20.41

23.912

2.480

1

43

18.51

26.419

4.029

The ROTEM group was analyzed with a logistic regression test for the dependent
variable Mortality with the independent variables of age, gender, BMI, ISS, and Number of
blood products and no statistical significance was found (p>0.05), (Table 6).
Table 6: Logistic Regression Analysis Comparing ROTEM with Mortality among Adult Trauma
Patients Who Received Blood Products Following a Traumatic Blunt Force or Penetration to the
Abdomen
B
Step 1a

S.E.

Wald

df

Sig.

Exp(B)

Age

.010

.015

.454

1

.501

1.010

Gender M1 and F2

.578

.579

.997

1

.318

1.782

BMI

.038

.030

1.645

1

.200

1.039

-.002

.026

.009

1

.926

.998

.843

.569

2.193

1

.139

2.323

.005

.007

.589

1

.443

1.005

Injury Severity Score (ISS)
TEG/ROTEM Whole Blood
Assay
Number of Blood Products
Used

Constant
-4.665
1.482
9.915
1
.002
.009
Dependent Variable: Mortality. BMI=Body Mass Index, TEG=Thromboelastography, ROTEM=Rotational Thromboelastometry
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The ROTEM group was analyzed with a logistic regression analysis between the
dependent variable Morbidity (CHF), and the independent variables that included age, gender,
BMI, ISS, and Number of blood products with no statistical significance found (p>0.05), (Table
7).
Table 7: Logistic Regression Analysis Comparing ROTEM with Congestive Heart Failure (CHF)
among Adult Trauma Patients Who Received Blood Products Following a Traumatic Blunt
Force or Penetration to the Abdomen
B
Step 1a

Age

S.E.

Wald

df

Sig.

Exp(B)

.213

.109

3.823

1

.051

1.237

Gender M1 and F2

1.572

1.629

.931

1

.335

4.815

BMI

-.089

.125

.515

1

.473

.915

Injury Severity Score (ISS)

-.280

.200

1.960

1

.161

.755

-2.869

2.130

1.815

1

.178

.057

.034

.034

.993

1

.319

1.034

Constant
-11.378
6.259
3.305
1
.069
Dependent Variable: Morbidity (CHF). BMI=Body Mass Index, TEG=Thromboelastography, ROTEM=Rotational
Thromboelastometry

.000

TEG/ROTEM Whole Blood
Assay
Number of Blood Products
Used

The ROTEM group was analyzed with a logistic regression analysis between the
dependent variable Morbidity (Pulmonary Edema) and the independent variables of age, gender,
BMI, ISS, and Number of blood products with no statistical significance found (p>0.05), (Table
8).
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Table 8: Logistic Regression Analysis Comparing ROTEM with Pulmonary Edema with Adult
Trauma Patients Who Received Blood Products Following a Traumatic Blunt Force or
Penetration to the Abdomen
B
Step 1a

S.E.

Wald

df

Sig.

Exp(B)

Age

.009

.018

.277

1

.599

1.009

Gender M1 and F2

.439

.675

.422

1

.516

1.550

BMI

.016

.019

.654

1

.419

1.016

Injury Severity Score (ISS)

.040

.027

2.100

1

.147

1.041

.045

.738

.004

1

.951

1.047

.004

.007

.322

1

.571

1.004

TEG/ROTEM Whole Blood
Assay
Number of Blood Products
Used

Constant
-5.049
1.572
10.322
1
.001
.006
Dependent Variable: Morbidity (Pulmonary Edema). BMI=Body Mass Index, TEG=Thromboelastography, ROTEM=Rotational
Thromboelastometry

DISCUSSION
Discussion of Study Results
It was indicated that TEG/ROTEM are not interrelated with routine coagulation tests (Da
Luz et al., 2013). This study also identified that rapid TEG (r-TEG) provides the earliest
prediction of blood products to be transfused and can be used as a point of care for the treatment
of hemorrhaging trauma patients for faster results. Schochl et al. (2012), reported that whole
blood assay tests provided personalized therapy according to the needs of the trauma patient in
contrast to the predetermined protocol of dispensing allogeneic blood products. These authors
further stated how the individualized care decreased the risks of underestimating or
overestimating the number of blood products needed. This present study revealed a statistical
significance between the mortality rate and the case group indicating a higher percentage
compared to the control group. It is difficult to determine if there is a clinical significance due to
the limitations of this study and the lack of sufficient cases to support ROTEM use. For this
study, there were only 43 ROTEM cases that could be used compared to 136 Conventional
15

Coagulation test cases. Therefore, there was not sufficient sample size to support the hypothesis
for this study. Research has shown that TEG/ROTEM have been recommended as a point of care
test for trauma patients and more facilities need to be trained how to use, calibrate, and
understand the specialized variances in performing the test (Da Luz et al., 2013). The use of
ROTEM for trauma patients at CAMC General Hospital began in 2014 and, according to
research studies, can provide future success in the diagnosis and therapeutic interventions for
hemostasis.
Study Limitations
Several limitations were identified in this study. There were not enough ROTEM cases
for adequate comparison. Another limitation included unknown preexisting co-morbidities or
prescribed medications which could have influenced the treatment and outcome of trauma
patients perioperatively. The final limitation was the ROTEM cases included in this study also
had a Conventional Coagulation test done, and there was no indication as to which test the
interventions were prescribed.
IMPLICATIONS AND RECOMMENDATIONS
A future study comparing ROTEM whole blood assays and Conventional Coagulation
laboratory tests should be done when ROTEM has been utilized at CAMC General Hospital for a
longer period, and enough ROTEM cases are available for collection. A prospective study could
be done as ROTEM whole blood assay is being used for trauma cases to determine if there is
clinical significance between the two laboratory pathways and the interventions provided.
Another study on ROTEM use could be conducted to include a detailed prediction of the type
and number of blood products to be given according to the ROTEM algorithm and the outcomes
compared with Conventional Coagulation tests. Finally, a study can be conducted comparing the

16

timing of the results provided for trauma patients with that of the timing of Conventional
Coagulation tests results.
CONCLUSION
In this present study, the use of ROTEM whole blood assay resulting in fewer blood products
infused and decreased morbidity and mortality rate could not be determined due to the limited
number of ROTEM cases available. Statistical significance was found between the mortality rate
and the ROTEM group. The mortality rate among the ROTEM group was found to have a higher
percentage and was statistically significant compared to the Conventional group.
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APPENDIX A

Number of
Blood Products
Used
Age
Mortality (alive
or dead)
Pulmonary
Edema(Y/N)
CHF(Y/N)
Length of Stay
Conventional
Coagulation
Test (Y/N)

TEG/ROTEM
Whole Blood
Assay
BMI
Injury Severity
Score
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
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